Cyclic Vomiting Syndrome, Mitochondrial Dysfunction, and Treatment

Mitochondria are small structures within cells that are responsible for producing energy and supporting many essential cellular functions. They generate more than 90% of the energy required for normal organ and body function. When mitochondrial function is impaired, energy production declines, which can lead to cellular injury and, in severe cases, cell death. If this process affects multiple tissues, entire organ systems may become compromised.

Organs with the highest energy demands—such as the brain, heart, muscles, and lungs—are typically the most affected. Because mitochondrial dysfunction can impact many systems simultaneously and present differently in each individual, mitochondrial disease can be difficult to diagnose. Symptoms may include seizures, stroke-like episodes, developmental delay, muscle weakness, gastrointestinal dysfunction, and autonomic nervous system abnormalities. Although mitochondrial disorders most often present in childhood, adult-onset disease is increasingly recognized. Mitochondrial dysfunction is now understood to contribute to a wide range of conditions, including Cyclic Vomiting Syndrome (CVS).

Genetics and Maternal Inheritance

Genetic changes affecting mitochondrial function can occur in two places: in the DNA located in the cell nucleus (nuclear DNA) or in the DNA contained within the mitochondria themselves (mitochondrial DNA, or mtDNA).

Unlike nuclear DNA—which is inherited from both parents—mtDNA is inherited exclusively from the mother. As a result, conditions linked to mitochondrial dysfunction often follow a maternal inheritance pattern. In families affected by CVS, conditions such as migraine, irritable bowel syndrome, depression, and thyroid disorders are frequently reported among maternal relatives.

The possible connection between CVS and mitochondrial dysfunction was first suggested by observations that CVS appeared to be inherited through the maternal line in some families. Since then, mitochondrial DNA mutations, deletions, and other abnormalities have been identified in a subset of individuals with CVS, as well as mitochondrial-related conditions in their maternal relatives.

Evidence Linking CVS and Mitochondrial Dysfunction

Cyclic vomiting has been reported in individuals with known mitochondrial DNA mutations, including those associated with MELAS syndrome. CVS has also been observed in children with established mitochondrial disorders, sometimes occurring alongside neurological, developmental, or growth-related problems, and sometimes as the primary or sole manifestation.

Studies of families affected by CVS suggest that while direct inheritance of CVS from a parent is uncommon, multiple family members may be affected, with inheritance patterns predominantly following the maternal line. Certain mitochondrial DNA variants appear more frequently in children with CVS and may increase susceptibility to the condition.

Research suggests that these genetic variations do not cause CVS directly in a single-gene manner. Instead, mitochondrial dysfunction appears to act as a contributing factor that increases vulnerability to episodes, particularly during periods of increased energy demand.

A Proposed Mechanism

One leading hypothesis proposes that impaired mitochondrial energy production limits the body’s ability to respond to stress. During times of increased metabolic demand—such as illness, emotional stress, excitement, or sleep deprivation—energy shortages may trigger vomiting episodes in susceptible individuals.

Importantly, mitochondrial dysfunction does not play the same role in all patients with CVS. In some individuals, it is a major driver of disease and is associated with multiple systemic symptoms. In others, it may be one of several contributing factors. Some patients experience only CVS symptoms, while others show additional features typical of mitochondrial disorders, such as muscle weakness, neurological symptoms, developmental delays, gastrointestinal dysmotility, or autonomic dysfunction.

Treatment Approaches Targeting Mitochondrial Function

Improved understanding of the biological mechanisms underlying CVS has led to the development of treatment strategies aimed at addressing potential root causes. Two nutritional supplements—coenzyme Q10 and L-carnitine—have been used to support mitochondrial energy production in a variety of conditions.

Retrospective studies suggest that the use of these supplements, combined with a dietary strategy focused on avoiding prolonged fasting (for example, regular meals and snacks throughout the day), may reduce the frequency or severity of CVS episodes in some patients. In individuals who do not respond adequately to supplements alone, the addition of preventive medications commonly used in CVS management has been shown to further reduce or resolve episodes.

Overall, treatments targeting mitochondrial support have generally been well tolerated, with few reported side effects. While such approaches may not yet be universally adopted in clinical practice, evidence indicates that effective preventive treatment options for CVS do exist and may be beneficial for selected patients.